@article{ref1,
title="The Subcutaneous Injection of Organophosphate: A Case Report",
journal="International journal of medical toxicology and forensic medicine",
year="2021",
author="Zoofaghari, S. and Dehkordi, A.F. and Nemati, K. and Hashemzadeh, M. and Otroshi, A.",
volume="11",
number="4",
pages="-",
abstract="Organophosphate (OP) poisoning is prevalent in developing countries. Toxicity occurs by voluntary injection, inhalation, and absorption. Self-injection is rare. The current case report describes a 61-y/o male with subcutaneous self-injected one cc OP poisoning presenting with delayed drowsiness, nausea, and vomiting. He was treated and presented a good clinical response to treatment with pralidoxime and had a successful recovery. Diagnosis of OP compound toxicity by the parenteral route is a challenge. By observing patients, the dose, and the time between poisoning until the time to start treatment, we can conclude different presentations and outcomes of OP poisoning. © 2021 Shahid Beheshti University of Medical Sciences. All rights reserved.<p /><p>Language: en</p>",
language="en",
issn="2251-8762",
doi="10.32598/ijmtfm.v11i4.34343",
url="http://dx.doi.org/10.32598/ijmtfm.v11i4.34343"
}